Global Stem Cells Group has announced plans to host an international symposium on stem cell research in Santiago, Chile. The symposium will feature some of the world’s most prominent scientific experts in stem cell and regenerative medicine, who will provide a full day of high-level scientific discussion for medical professionals in general practice.

The symposium agenda will include sessions on:

• Molecular biology
• Clinical advances in stem cell research
• Models of treatment in surgical and cosmetic applications, and in clinical conditions
• Technological advances
• Application of minimally manipulated stem cells in the physician’s office
• Stem cells, regenerative medicine and its application in anti-aging medicine
• Medical legal issues

The Santiago, Chile symposium includes a full day, hands-on training session to provide participating physicians and qualified medical professionals with state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells, along with clinical protocols. This popular training course is part of the Global Stem Cells Group’s commitment to the growing network of world-class stem cell researchers, treatment practitioners and investors committed to advancing stem cell medicine, and helping physicians bring treatments into the office for the benefit of patients.

The Santiago symposium will be held at Santo Tomas University in Santiago, Chile, and hosted by the Dean of Health Services Faculty, Fernando Espina Otero, M.D.

For more information on the Global Stem Cells Group Santiago, Chile symposium including the lineup of speakers, visit the stemcellconference.org website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/